Cargando…

Low Expression of Phosphodiesterase 2 (PDE2A) Promotes the Progression by Regulating Mitochondrial Morphology and ATP Content and Predicts Poor Prognosis in Hepatocellular Carcinoma

Phosphodiesterase 2 (PDE2A) modulates the levels of cAMP/cGMP and was recently found to be involved in mitochondria function regulation, closely related to multiple types of tumor progression. This study aimed to estimate the prognostic significance and biological effects of PDE2A on hepatocellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lin, Zhou, Jinchi, Zhao, Zifeng, Zhu, Yuhan, Xing, Jinliang, An, Jiaze, Guo, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818237/
https://www.ncbi.nlm.nih.gov/pubmed/36611861
http://dx.doi.org/10.3390/cells12010068
_version_ 1784864935934689280
author Chen, Lin
Zhou, Jinchi
Zhao, Zifeng
Zhu, Yuhan
Xing, Jinliang
An, Jiaze
Guo, Xu
author_facet Chen, Lin
Zhou, Jinchi
Zhao, Zifeng
Zhu, Yuhan
Xing, Jinliang
An, Jiaze
Guo, Xu
author_sort Chen, Lin
collection PubMed
description Phosphodiesterase 2 (PDE2A) modulates the levels of cAMP/cGMP and was recently found to be involved in mitochondria function regulation, closely related to multiple types of tumor progression. This study aimed to estimate the prognostic significance and biological effects of PDE2A on hepatocellular carcinoma (HCC). We comprehensively analyzed the PDE2A mRNA expression in HCC based on The Cancer Genome Atlas (TCGA) database and investigated the effects of PDE2A on the proliferation and metastatic capacity of HCC cells. PDE2A was downregulated in 25 cancer types, including HCC. Lower PDE2A expression was a protective factor in HCC and was negatively associated with serum AFP levels, tumor status, vascular invasion, histologic grade, and pathologic stage of HCC. Moreover, tumors with low PDE2A expression displayed a decreased immune function. Then, the ROC curve was used to assess the diagnostic ability of PDE2A in HCC (AUC = 0.823 in TCGA and AUC = 0.901 in GSE76427). Patients with low PDE2A expression exhibited worse outcomes compared with those with high PDE2A expression. Additionally, GO functional annotations demonstrated the involvement of PDE2A in the ECM organization, systems development, and ERK-related pathways, indicating that PDE2A might regulate HCC growth and metastasis. The in vitro experiments confirmed that overexpression of PDE2A inhibited proliferation, colony formation, migration, and invasion in two HCC cell lines (HLF and SNU-368), while inhibition of PDE2A has the opposite results. The mechanism of PDE2A’s effect on HCC cells is attributed to the change of mitochondrial morphology and ATP content. These data demonstrated that PDE2A closely participated in the regulation of HCC proliferation and metastasis and can be used as a predictive marker candidate and a potential therapeutic target for HCC.
format Online
Article
Text
id pubmed-9818237
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98182372023-01-07 Low Expression of Phosphodiesterase 2 (PDE2A) Promotes the Progression by Regulating Mitochondrial Morphology and ATP Content and Predicts Poor Prognosis in Hepatocellular Carcinoma Chen, Lin Zhou, Jinchi Zhao, Zifeng Zhu, Yuhan Xing, Jinliang An, Jiaze Guo, Xu Cells Article Phosphodiesterase 2 (PDE2A) modulates the levels of cAMP/cGMP and was recently found to be involved in mitochondria function regulation, closely related to multiple types of tumor progression. This study aimed to estimate the prognostic significance and biological effects of PDE2A on hepatocellular carcinoma (HCC). We comprehensively analyzed the PDE2A mRNA expression in HCC based on The Cancer Genome Atlas (TCGA) database and investigated the effects of PDE2A on the proliferation and metastatic capacity of HCC cells. PDE2A was downregulated in 25 cancer types, including HCC. Lower PDE2A expression was a protective factor in HCC and was negatively associated with serum AFP levels, tumor status, vascular invasion, histologic grade, and pathologic stage of HCC. Moreover, tumors with low PDE2A expression displayed a decreased immune function. Then, the ROC curve was used to assess the diagnostic ability of PDE2A in HCC (AUC = 0.823 in TCGA and AUC = 0.901 in GSE76427). Patients with low PDE2A expression exhibited worse outcomes compared with those with high PDE2A expression. Additionally, GO functional annotations demonstrated the involvement of PDE2A in the ECM organization, systems development, and ERK-related pathways, indicating that PDE2A might regulate HCC growth and metastasis. The in vitro experiments confirmed that overexpression of PDE2A inhibited proliferation, colony formation, migration, and invasion in two HCC cell lines (HLF and SNU-368), while inhibition of PDE2A has the opposite results. The mechanism of PDE2A’s effect on HCC cells is attributed to the change of mitochondrial morphology and ATP content. These data demonstrated that PDE2A closely participated in the regulation of HCC proliferation and metastasis and can be used as a predictive marker candidate and a potential therapeutic target for HCC. MDPI 2022-12-23 /pmc/articles/PMC9818237/ /pubmed/36611861 http://dx.doi.org/10.3390/cells12010068 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chen, Lin
Zhou, Jinchi
Zhao, Zifeng
Zhu, Yuhan
Xing, Jinliang
An, Jiaze
Guo, Xu
Low Expression of Phosphodiesterase 2 (PDE2A) Promotes the Progression by Regulating Mitochondrial Morphology and ATP Content and Predicts Poor Prognosis in Hepatocellular Carcinoma
title Low Expression of Phosphodiesterase 2 (PDE2A) Promotes the Progression by Regulating Mitochondrial Morphology and ATP Content and Predicts Poor Prognosis in Hepatocellular Carcinoma
title_full Low Expression of Phosphodiesterase 2 (PDE2A) Promotes the Progression by Regulating Mitochondrial Morphology and ATP Content and Predicts Poor Prognosis in Hepatocellular Carcinoma
title_fullStr Low Expression of Phosphodiesterase 2 (PDE2A) Promotes the Progression by Regulating Mitochondrial Morphology and ATP Content and Predicts Poor Prognosis in Hepatocellular Carcinoma
title_full_unstemmed Low Expression of Phosphodiesterase 2 (PDE2A) Promotes the Progression by Regulating Mitochondrial Morphology and ATP Content and Predicts Poor Prognosis in Hepatocellular Carcinoma
title_short Low Expression of Phosphodiesterase 2 (PDE2A) Promotes the Progression by Regulating Mitochondrial Morphology and ATP Content and Predicts Poor Prognosis in Hepatocellular Carcinoma
title_sort low expression of phosphodiesterase 2 (pde2a) promotes the progression by regulating mitochondrial morphology and atp content and predicts poor prognosis in hepatocellular carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818237/
https://www.ncbi.nlm.nih.gov/pubmed/36611861
http://dx.doi.org/10.3390/cells12010068
work_keys_str_mv AT chenlin lowexpressionofphosphodiesterase2pde2apromotestheprogressionbyregulatingmitochondrialmorphologyandatpcontentandpredictspoorprognosisinhepatocellularcarcinoma
AT zhoujinchi lowexpressionofphosphodiesterase2pde2apromotestheprogressionbyregulatingmitochondrialmorphologyandatpcontentandpredictspoorprognosisinhepatocellularcarcinoma
AT zhaozifeng lowexpressionofphosphodiesterase2pde2apromotestheprogressionbyregulatingmitochondrialmorphologyandatpcontentandpredictspoorprognosisinhepatocellularcarcinoma
AT zhuyuhan lowexpressionofphosphodiesterase2pde2apromotestheprogressionbyregulatingmitochondrialmorphologyandatpcontentandpredictspoorprognosisinhepatocellularcarcinoma
AT xingjinliang lowexpressionofphosphodiesterase2pde2apromotestheprogressionbyregulatingmitochondrialmorphologyandatpcontentandpredictspoorprognosisinhepatocellularcarcinoma
AT anjiaze lowexpressionofphosphodiesterase2pde2apromotestheprogressionbyregulatingmitochondrialmorphologyandatpcontentandpredictspoorprognosisinhepatocellularcarcinoma
AT guoxu lowexpressionofphosphodiesterase2pde2apromotestheprogressionbyregulatingmitochondrialmorphologyandatpcontentandpredictspoorprognosisinhepatocellularcarcinoma